Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive NESA Neuromodulation Versus Transcutaneous Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder

NCT07019597 is registered in ClinicalTrials.gov with Daniel David Álamo Arce as lead sponsor.

NCT NCT07019597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07019597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive NESA Neuromodulation Versus Transcutaneous Posterior Tibial Nerve Stimulation for the Treatment of Overactive Bladder
Lead sponsor
Daniel David Álamo Arce
Phase
Not applicable
Overall status
Recruiting
Start date
May 1, 2025
Completion date
September 1, 2025
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder dysfunction